Validation of CHA2DS2-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation - An analysis of the J-RHYTHM registry

Circulation Journal

Volumn 78, Issue 7, 2014, Pages 1593-1599

  Okumura, Ken ^a   Inoue, Hiroshi ^b   Atarashi, Hirotsugu ^c   Yamashita, Takeshi ^d   Tomita, Hirofumi ^a   Origasa, Hideki ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

^d THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; HAS BLED; Major bleeding; Thromboembolism

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

AGED; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CLINICAL FEATURE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HAS BLED SCORE; HEART ATRIUM ARRHYTHMIA; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONVALVULAR ATRIAL FIBRILLATION; OBSERVATIONAL STUDY; RISK ASSESSMENT; THROMBOEMBOLISM; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CHEMICALLY INDUCED; FOLLOW UP; HEALTH STATUS INDICATOR; HEMORRHAGE; MIDDLE AGED; REGISTER; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HEMORRHAGE; HUMANS; JAPAN; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 84903146221     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0144     Document Type: Article

References (21)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
2. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al, Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011; 342: d124, doi:10.1136/bmj.d124.
3. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: The Belgrade atrial fibrillation study. Circ Arrhythm Electrophysiol 2012; 5: 319-326.
4. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
5. Taillandier S, Olesen JB, Clementy N, Lagrenade I, Babuty D, Lip GY, et al. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=0 in a community-based cohort study. J Cardiovasc Electrophysiol 2012; 23: 708-713.
6. Coppens M, Eikelboom JW, Hart RG, Yusuf S, Lip GY, Dorian P, et al. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J 2013; 34: 170-176.
7. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial fibrillation. Circ J 2012; 76: 2289-2304.
8. Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 2011; 9: 39-48.
9. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010; 138: 1093-1100.
10. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J 2012; 33: 1500-1510.
11. Lane DA, Lip GY. Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation 2012; 126: 860-865.
12. Lip GY. Implications of the CHA2DS2-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med 2011; 124: 111-114.
13. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
14. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation: Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747.
15. Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation--the J-RHYTHM Registry study design. J Cardiol 2011; 57: 95-99.
16. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: A report from the J-RHYTHM Registry. Circ J 2011; 75: 1328-1333.
17. J-RHYTHM Registry Investigators. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan: Subanalysis of the J-RHYTHM Registry. Circ J 2011; 75: 2357-2362.
18. Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, et al. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with nonvalvular atrial fibrillation: Results of the J-RHYTHM Registry. Circ J 2013; 77: 2264-2270.
19. Inoue H, Atarashi H, Okumura K, Yamashita T, Origasa H, Kumagai N, et al. Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. Am J Cardiol 2014; 113: 957-962.
20. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study. Thromb Haemost 2012; 107: 1172-1179.
21. Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, et al. Clinical outcome in Japanese elderly patients with nonvalvular atrial fibrillation taking warfarin: A single-center observational study. Thromb Res 2012; 130: 21-26.